Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer

Gary S Leiserowitz, Anthony H. Russell, Walter K. Kinney, Lloyd H Smith, Michael H. Taylor, Sidney A Scudder

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Objective. Primary surgical resection of locally advanced squamous cancer of the vulva may compromise the integrity of important midline structures such as the anus, clitoris, urethra, and vagina. Chemoradiation (synchronous radiation and cytotoxic chemotherapy) has been used as alternative initial treatment which may serve as definitive management for some patients, or may reduce the scope and functional sequelae of subsequent surgery in others. Inguinofemoral node dissection is associated with substantial risk of both acute and late morbidity, prompting consideration of elective inclusion of groin nodes within the irradiated volume and deletion of subsequent groin surgery. Concern that disease relapse in the groins is potentially fatal suggested the prudence of formal outcome assessment of our recent experience with prophylactic treatment of clinically uninvolved groin nodes in the context of concurrent chemoradiation for locally advanced primary vulvar cancer. Methods. A review was conducted of 23 previously untreated patients with locally advanced squamous cancer of the vulva (2 T2, 20 T3, 1 T4) and clinically uninvolved groin nodes (1969 FIGO stages 14 N0, 4 N1, and 5 N2 with negative node biopsies) who were treated since 1987 with chemoradiation administered to a volume electively including bilateral inguinofemoral nodes. These patients did not undergo subsequent groin surgery. Results. With follow-up from 6 to 98 months (mean, 45.3 months; median; 42 months), no patient has failed in the prophylactically irradiated inguinofemoral nodes. No patient has developed lymphedema, vascular insufficiency, or neurological injury in a lower extremity and no patient has experienced aseptic necrosis of a femur. Conclusions. Elective irradiation of the groin nodes in the context of initial chemoradiation for locally advanced vulvar cancer is an effective therapy associated with acceptable acute toxicity and minimal late sequelae. It constitutes a sensible alternative to groin dissection in this patient population.

Original languageEnglish (US)
Pages (from-to)509-514
Number of pages6
JournalGynecologic Oncology
Volume66
Issue number3
DOIs
StatePublished - Sep 1997

Fingerprint

Vulvar Neoplasms
Groin
Lymph Nodes
Dissection
Clitoris
Lymphedema
Anal Canal
Vagina
Urethra
Femur
Blood Vessels
Lower Extremity
Necrosis
Therapeutics
Outcome Assessment (Health Care)
Radiation
Morbidity
Biopsy
Recurrence
Drug Therapy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. / Leiserowitz, Gary S; Russell, Anthony H.; Kinney, Walter K.; Smith, Lloyd H; Taylor, Michael H.; Scudder, Sidney A.

In: Gynecologic Oncology, Vol. 66, No. 3, 09.1997, p. 509-514.

Research output: Contribution to journalArticle

@article{756718934cb545fb9c518c796c01550e,
title = "Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer",
abstract = "Objective. Primary surgical resection of locally advanced squamous cancer of the vulva may compromise the integrity of important midline structures such as the anus, clitoris, urethra, and vagina. Chemoradiation (synchronous radiation and cytotoxic chemotherapy) has been used as alternative initial treatment which may serve as definitive management for some patients, or may reduce the scope and functional sequelae of subsequent surgery in others. Inguinofemoral node dissection is associated with substantial risk of both acute and late morbidity, prompting consideration of elective inclusion of groin nodes within the irradiated volume and deletion of subsequent groin surgery. Concern that disease relapse in the groins is potentially fatal suggested the prudence of formal outcome assessment of our recent experience with prophylactic treatment of clinically uninvolved groin nodes in the context of concurrent chemoradiation for locally advanced primary vulvar cancer. Methods. A review was conducted of 23 previously untreated patients with locally advanced squamous cancer of the vulva (2 T2, 20 T3, 1 T4) and clinically uninvolved groin nodes (1969 FIGO stages 14 N0, 4 N1, and 5 N2 with negative node biopsies) who were treated since 1987 with chemoradiation administered to a volume electively including bilateral inguinofemoral nodes. These patients did not undergo subsequent groin surgery. Results. With follow-up from 6 to 98 months (mean, 45.3 months; median; 42 months), no patient has failed in the prophylactically irradiated inguinofemoral nodes. No patient has developed lymphedema, vascular insufficiency, or neurological injury in a lower extremity and no patient has experienced aseptic necrosis of a femur. Conclusions. Elective irradiation of the groin nodes in the context of initial chemoradiation for locally advanced vulvar cancer is an effective therapy associated with acceptable acute toxicity and minimal late sequelae. It constitutes a sensible alternative to groin dissection in this patient population.",
author = "Leiserowitz, {Gary S} and Russell, {Anthony H.} and Kinney, {Walter K.} and Smith, {Lloyd H} and Taylor, {Michael H.} and Scudder, {Sidney A}",
year = "1997",
month = "9",
doi = "10.1006/gyno.1997.4804",
language = "English (US)",
volume = "66",
pages = "509--514",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer

AU - Leiserowitz, Gary S

AU - Russell, Anthony H.

AU - Kinney, Walter K.

AU - Smith, Lloyd H

AU - Taylor, Michael H.

AU - Scudder, Sidney A

PY - 1997/9

Y1 - 1997/9

N2 - Objective. Primary surgical resection of locally advanced squamous cancer of the vulva may compromise the integrity of important midline structures such as the anus, clitoris, urethra, and vagina. Chemoradiation (synchronous radiation and cytotoxic chemotherapy) has been used as alternative initial treatment which may serve as definitive management for some patients, or may reduce the scope and functional sequelae of subsequent surgery in others. Inguinofemoral node dissection is associated with substantial risk of both acute and late morbidity, prompting consideration of elective inclusion of groin nodes within the irradiated volume and deletion of subsequent groin surgery. Concern that disease relapse in the groins is potentially fatal suggested the prudence of formal outcome assessment of our recent experience with prophylactic treatment of clinically uninvolved groin nodes in the context of concurrent chemoradiation for locally advanced primary vulvar cancer. Methods. A review was conducted of 23 previously untreated patients with locally advanced squamous cancer of the vulva (2 T2, 20 T3, 1 T4) and clinically uninvolved groin nodes (1969 FIGO stages 14 N0, 4 N1, and 5 N2 with negative node biopsies) who were treated since 1987 with chemoradiation administered to a volume electively including bilateral inguinofemoral nodes. These patients did not undergo subsequent groin surgery. Results. With follow-up from 6 to 98 months (mean, 45.3 months; median; 42 months), no patient has failed in the prophylactically irradiated inguinofemoral nodes. No patient has developed lymphedema, vascular insufficiency, or neurological injury in a lower extremity and no patient has experienced aseptic necrosis of a femur. Conclusions. Elective irradiation of the groin nodes in the context of initial chemoradiation for locally advanced vulvar cancer is an effective therapy associated with acceptable acute toxicity and minimal late sequelae. It constitutes a sensible alternative to groin dissection in this patient population.

AB - Objective. Primary surgical resection of locally advanced squamous cancer of the vulva may compromise the integrity of important midline structures such as the anus, clitoris, urethra, and vagina. Chemoradiation (synchronous radiation and cytotoxic chemotherapy) has been used as alternative initial treatment which may serve as definitive management for some patients, or may reduce the scope and functional sequelae of subsequent surgery in others. Inguinofemoral node dissection is associated with substantial risk of both acute and late morbidity, prompting consideration of elective inclusion of groin nodes within the irradiated volume and deletion of subsequent groin surgery. Concern that disease relapse in the groins is potentially fatal suggested the prudence of formal outcome assessment of our recent experience with prophylactic treatment of clinically uninvolved groin nodes in the context of concurrent chemoradiation for locally advanced primary vulvar cancer. Methods. A review was conducted of 23 previously untreated patients with locally advanced squamous cancer of the vulva (2 T2, 20 T3, 1 T4) and clinically uninvolved groin nodes (1969 FIGO stages 14 N0, 4 N1, and 5 N2 with negative node biopsies) who were treated since 1987 with chemoradiation administered to a volume electively including bilateral inguinofemoral nodes. These patients did not undergo subsequent groin surgery. Results. With follow-up from 6 to 98 months (mean, 45.3 months; median; 42 months), no patient has failed in the prophylactically irradiated inguinofemoral nodes. No patient has developed lymphedema, vascular insufficiency, or neurological injury in a lower extremity and no patient has experienced aseptic necrosis of a femur. Conclusions. Elective irradiation of the groin nodes in the context of initial chemoradiation for locally advanced vulvar cancer is an effective therapy associated with acceptable acute toxicity and minimal late sequelae. It constitutes a sensible alternative to groin dissection in this patient population.

UR - http://www.scopus.com/inward/record.url?scp=0031240049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031240049&partnerID=8YFLogxK

U2 - 10.1006/gyno.1997.4804

DO - 10.1006/gyno.1997.4804

M3 - Article

C2 - 9299268

AN - SCOPUS:0031240049

VL - 66

SP - 509

EP - 514

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -